Position in LCTX
as of Mar 31, 2026
· filed May 5, 2026
Position Value
$2,165,327
+$1,859,507 QoQ
Shares Held
1,370,461
+648.4% QoQ
Ownership
0.550%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2020
25 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in LCTX Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026UBS Group AG holds $8,307,109,707 across 562 Biotechnology names. LCTX ranks #204 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ROIV |
Roivant Sciences Ltd.
|
22,619,472 | $626,559,372 | |
| 2 | PTGX |
Protagonist Therapeutics, Inc
|
5,177,796 | $545,739,697 | |
| 3 | ABVX |
Abivax S.A.
|
4,547,406 | $506,353,656 | |
| 4 | RVMD |
Revolution Medicines, Inc.
|
4,386,791 | $426,615,424 | |
| 5 | INSM |
INSMED Inc
|
1,737,481 | $284,112,890 | |
| 6 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
630,618 | $281,596,158 | |
| 7 | APLS |
Apellis Pharmaceuticals, Inc.
|
6,206,681 | $249,694,775 | |
| 8 | REGN |
Regeneron Pharmaceuticals, Inc.
|
299,979 | $231,775,770 |
All Filings in LCTX
Export CSV
25 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $2,165,327 | 1,370,461 | Shares | Defined | 2026-05-05 | |
| 2025-12-31 | $305,820 | 183,127 | Shares | Defined | 2026-01-29 | |
| 2025-09-30 | $351,653 | 208,080 | Shares | Defined | 2025-11-13 | |
| 2025-06-30 | $207,114 | 227,600 | Shares | Defined | 2025-08-14 | |
| 2025-03-31 | $118,760 | 263,917 | Shares | Defined | 2025-05-13 | |
| 2024-12-31 | $110,443 | 220,888 | Shares | Defined | 2025-02-14 | |
| 2024-09-30 | $156,000 | 171,431 | Shares | Defined | 2024-11-14 | |
| 2024-06-30 | $76,466 | 76,466 | Shares | Defined | 2024-08-14 | |
| 2024-03-31 | $207,305 | 140,072 | Shares | Defined | 2024-05-13 | |
| 2023-12-31 | $157,533 | 144,527 | Shares | Defined | 2024-02-09 | |
| 2023-09-30 | $62,504 | 52,971 | Shares | Defined | 2023-11-09 | |
| 2023-06-30 | $86,060 | 61,037 | Shares | Defined | 2023-08-11 | |
| 2023-03-31 | $4,879 | 3,253 | Shares | Defined | 2023-05-12 | |
| 2022-12-31 | $12,291 | 10,506 | Shares | Defined | 2023-02-08 | |
| 2022-09-30 | $1,470 | 1,302 | Shares | Defined | 2022-11-10 | |
| 2022-06-30 | $18,043 | 11,420 | Shares | Defined | 2022-08-10 | |
| 2022-03-31 | $1,376 | 894 | Shares | Defined | 2022-05-16 | |
| 2021-12-31 | $97,832 | 39,932 | Shares | Defined | 2022-02-14 | |
| 2021-09-30 | $523,407 | 207,702 | Shares | Defined | 2021-11-15 | |
| 2021-06-30 | $12,955 | 4,546 | Shares | Defined | 2021-08-13 | |
| 2021-03-31 | $17,241 | 7,337 | Shares | Defined | 2021-05-12 | |
| 2020-12-31 | $43,299 | 24,602 | Shares | Defined | 2021-02-11 | |
| 2020-09-30 | $1,051 | 1,119 | Shares | Defined | 2020-11-12 | |
| 2020-06-30 | $1,180 | 1,357 | Shares | Defined | 2020-07-31 | |
| 2020-03-31 | $58,859 | 70,916 | Shares | Defined | 2020-05-01 | |
| No filing history on record for this holder in this stock. | ||||||